PW | Pharmaceutisch Weekblad

Price orphan drugs can be reduced drastically

Better diagnostic testing allows tailored therapy for an increasing number of diseases. This has led to a growing number of conditions classified as ‘orphan diseases’. A welcome source of income for the pharmaceutical industry, but a growing expense for society. It’s time for a change of course.

Bevindt zich in Achtergrond - 28 september 2012 | door J.R.B.J. Brouwers

Apotheek Gasthuisberg on Price orphan drugs can be reduced drastically

If compounding (clinial) pharmacists with "GMP-certified manufacturing units" should return in order to reduce healthcare costs for rare diseases, we need to develop pharmacopoeial monographies [...]

Bevindt zich in Achtergrond - 30 september 2012

Working towards a healthier world

For a full century, the International Pharmaceutical Federation (FIP) has brought together pharmacists and pharmaceutical scientists from around the world. The goal: to advance pharmacy practice and science so that they may ensure safe, cost-effective use of medicinal products.

Bevindt zich in Achtergrond - 28 september 2012 | door Edwin Bos

Visit the pharmacy for medical apps

Apps on smartphones can play a key role in compliance. Using a game, patients set goals for themselves and share their scores on Facebook. Internet expert Martijn Hulst: “The pharmacy is the ideal place for providing medical apps.”

Bevindt zich in Achtergrond - 28 september 2012 | door Edwin Bos

Creating a future

Message from the FIP President

Bevindt zich in Achtergrond - 28 september 2012 | door Michel Buchmann

Personalised medicine: back to the future

Innovation in the field of pharmaceutical medicine is advancing faster than the healthcare system can adapt to it. Personalised medicine is widely acknowledged to be the future. Could the current trend see the return of the compounding pharmacist in our high streets?

Bevindt zich in Achtergrond - 28 september 2012 | door Dave Sharma

Personalised medicine heralds new era for clinical trials cancer drugs

A feature article appeared in the Daily Telegraph describing the agony of a patient with non-small cell lung cancer (NSCLC) whose best chance of increased survival lay in being able to access a drug called crizotinib [1].

Bevindt zich in Achtergrond - 28 september 2012 | door Libby Hardy

Fake medicines: out of the supply chain

The battle to stop falsified medicines entering the supply chain is ongoing. Only last month, the Medicines and Healthcare products Regulatory Agency’s enforcement team seized a haul of counterfeit erectile dysfunction tablets with an estimated value of £140,000. To help tackle the problem the European Commission published the ‘Falsified Medicines Directive’, which could have considerable implications for pharmacists.

Bevindt zich in Achtergrond - 28 september 2012 | door Kate Towers

Looking at the future

Message from the PW Editor-in-chief

Bevindt zich in Achtergrond - 28 september 2012 | door Elma Stitzinger

‘Only an international approach works’

The problems associated with resistant bacteria are rapidly increasing worldwide. The ecosystem is already contaminated. The number of victims of infection is growing, but a solution remains elusive.